News Focus
News Focus
Followers 61
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: cjgaddy post# 147662

Thursday, 11/07/2013 1:31:37 PM

Thursday, November 07, 2013 1:31:37 PM

Post# of 347009
"...significantly improved tumor free long-term survival and apparent cures in 35%…"

Peregrine's proprietary anti-PS tech is already producing cancer cures in pre-clinical. Dr. Brekken says to watch for 200%-300% increases in responses when anti-PS is used in combination with downstream immunotherapies. Those combo studies were started in June 2013, and should soon be seen in posters, and a possible phase I immunotherapy combination trial before year end. My guess is that the phase I trial would be a collaboration with a BP.

IMO

sunstar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y